Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance comparison of Affymetrix SNP6.0 and cytogenetic 2.7M whole-genome microarrays in complex cancer samples.

Cytogenetic and genome research - 1 Jan 2013

Bødker J S, Gyrup C, Johansen P, Schmitz A, Madsen J, Johnsen H E, Bøgsted M, Dybkær K, Nyegaard M

Abstract excerpt

The Affymetrix cytogenetic 2.7M whole-genome microarray (Cyto2.7M) detects genomic aberrations. The Cyto2.7M array has increased coverage in regions with cancer-related genes, ~4-fold reduced processing time, and 5-fold reduced input requirements (100 ng) compared to the commonly used Affymetrix SNP6.0 genome-wide microarray (SNP6.0). We set out to compare the performance of these microarrays on cancer samples...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to Cytogenetic Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to DNA, Neoplasm

Share to Genome, Human

Share to Loss of Heterozygosity

Share to Oligonucleotide Array Sequence Analysis

Share to Reproducibility of Results

Source

Identifiers

PMID: 23182917
DOI: 10.1159/000345125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance comparison of Affymetrix SNP6.0 and cytogenetic 2.7M whole-genome microarrays in complex cancer samples.PMID 23182917Read ↗

Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms.Semantic proximity Read ↗

Integrated detection and population-genetic analysis of SNPs and copy number variation.Semantic proximity Read ↗

Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.Semantic proximity Read ↗

Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.Semantic proximity Read ↗

Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays.Semantic proximity Read ↗

Genomic microarrays in the spotlight.Semantic proximity Read ↗

Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?Semantic proximity Read ↗

A systematic benchmark of copy number variation detection tools for high density SNP genotyping arrays.Semantic proximity Read ↗

Single nucleotide polymorphism microarray analysis of genetic alterations in cancer.Semantic proximity Read ↗

Identification of Copy Number Variants from SNP Arrays Using PennCNV.Semantic proximity Read ↗

Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies.Semantic proximity Read ↗

Comprehensive Assessment of Somatic Copy Number Variation Calling Using Next-Generation Sequencing DataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.